Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 6629 entries
Sorted by: Best Match Show Resources per page
Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101.

Journal of oncology

Braunstein MJ, Scott SS, Scott CM, Behrman S, Walter P, Wipf P, Coplan JD, Chrico W, Joseph D, Brodsky JL, Batuman O.
PMID: 21977030
J Oncol. 2011;2011:232037. doi: 10.1155/2011/232037. Epub 2011 Sep 29.

Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable, primarily due to the treatment-refractory/resistant nature of the disease. A rational approach to this compelling challenge is to develop new drugs that act synergistically with existing...

Cite
Braunstein MJ, Scott SS, Scott CM, et al. Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101. J Oncol. 2011;2011:232037doi: 10.1155/2011/232037.
Braunstein, M. J., Scott, S. S., Scott, C. M., Behrman, S., Walter, P., Wipf, P., Coplan, J. D., Chrico, W., Joseph, D., Brodsky, J. L., & Batuman, O. (2011). Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101. Journal of oncology, 2011232037. https://doi.org/10.1155/2011/232037
Braunstein, Marc J, et al. "Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101." Journal of oncology vol. 2011 (2011): 232037. doi: https://doi.org/10.1155/2011/232037
Braunstein MJ, Scott SS, Scott CM, Behrman S, Walter P, Wipf P, Coplan JD, Chrico W, Joseph D, Brodsky JL, Batuman O. Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101. J Oncol. 2011;2011:232037. doi: 10.1155/2011/232037. Epub 2011 Sep 29. PMID: 21977030; PMCID: PMC3184436.
Copy Download .nbib Format: NLM
Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin.

Journal of oncology

Sharma C, Vas AJ, Goala P, Gheewala TM, Rizvi TA, Hussain A.
PMID: 24624140
J Oncol. 2014;2014:321754. doi: 10.1155/2014/321754. Epub 2014 Jan 30.

The present study was designed to gain insight into the antiproliferative activity of ethanolic neem leaves extract (ENLE) alone or in combination with cisplatin by cell viability assay on human breast (MCF-7) and cervical (HeLa) cancer cells. Nuclear morphological...

Cite
Sharma C, Vas AJ, Goala P, et al. Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin. J Oncol. 2014;2014:321754doi: 10.1155/2014/321754.
Sharma, C., Vas, A. J., Goala, P., Gheewala, T. M., Rizvi, T. A., & Hussain, A. (2014). Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin. Journal of oncology, 2014321754. https://doi.org/10.1155/2014/321754
Sharma, Chhavi, et al. "Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin." Journal of oncology vol. 2014 (2014): 321754. doi: https://doi.org/10.1155/2014/321754
Sharma C, Vas AJ, Goala P, Gheewala TM, Rizvi TA, Hussain A. Ethanolic Neem (Azadirachta indica) Leaf Extract Prevents Growth of MCF-7 and HeLa Cells and Potentiates the Therapeutic Index of Cisplatin. J Oncol. 2014;2014:321754. doi: 10.1155/2014/321754. Epub 2014 Jan 30. PMID: 24624140; PMCID: PMC3929266.
Copy Download .nbib Format: NLM
Reply to F. Dayyani et al.

Journal of oncology practice

Accordino MK, Hershman DL.
PMID: 26837563
J Oncol Pract. 2016 Mar;12(3):277. doi: 10.1200/JOP.2015.009316. Epub 2016 Feb 02.

No abstract available.

Cite
Accordino MK, Hershman DL. Reply to F. Dayyani et al. J Oncol Pract. 2016;12(3):277doi: 10.1200/JOP.2015.009316.
Accordino, M. K., & Hershman, D. L. (2016). Reply to F. Dayyani et al. Journal of oncology practice, 12(3), 277. https://doi.org/10.1200/JOP.2015.009316
Accordino, Melissa K, and Hershman, Dawn L. "Reply to F. Dayyani et al." Journal of oncology practice vol. 12,3 (2016): 277. doi: https://doi.org/10.1200/JOP.2015.009316
Accordino MK, Hershman DL. Reply to F. Dayyani et al. J Oncol Pract. 2016 Mar;12(3):277. doi: 10.1200/JOP.2015.009316. Epub 2016 Feb 02. PMID: 26837563.
Copy Download .nbib Format: NLM
Transforming Cancer Survivorship Care: An Australian Experience.

Asia-Pacific journal of oncology nursing

Kinnane NA, Piper A, Wiley G, Nolte L, Evans J, Jefford M.
PMID: 28503637
Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):91-94. doi: 10.4103/2347-5625.204498.

No abstract available.

Cite
Kinnane NA, Piper A, Wiley G, et al. Transforming Cancer Survivorship Care: An Australian Experience. Asia Pac J Oncol Nurs. 2017;4(2):91-94doi: 10.4103/2347-5625.204498.
Kinnane, N. A., Piper, A., Wiley, G., Nolte, L., Evans, J., & Jefford, M. (2017). Transforming Cancer Survivorship Care: An Australian Experience. Asia-Pacific journal of oncology nursing, 4(2), 91-94. https://doi.org/10.4103/2347-5625.204498
Kinnane, Nicole A, et al. "Transforming Cancer Survivorship Care: An Australian Experience." Asia-Pacific journal of oncology nursing vol. 4,2 (2017): 91-94. doi: https://doi.org/10.4103/2347-5625.204498
Kinnane NA, Piper A, Wiley G, Nolte L, Evans J, Jefford M. Transforming Cancer Survivorship Care: An Australian Experience. Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):91-94. doi: 10.4103/2347-5625.204498. PMID: 28503637; PMCID: PMC5412159.
Copy Download .nbib Format: NLM
Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses.

Asia-Pacific journal of oncology nursing

Boyle DA.
PMID: 28503639
Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):98-103. doi: 10.4103/2347-5625.204497.

Hepatocellular carcinoma (HCC) is a prominent malignancy in the Asia-Pacific region. Despite considerable knowledge about it's scope and nature this malignancy remains incurable. This manuscript reviews the epidemiology of this cancer, its pathogenesis, risk factors, potential prevention, surveillance, treatment,...

Cite
Boyle DA. Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017;4(2):98-103doi: 10.4103/2347-5625.204497.
Boyle, D. A. (2017). Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia-Pacific journal of oncology nursing, 4(2), 98-103. https://doi.org/10.4103/2347-5625.204497
Boyle, Deborah A. "Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses." Asia-Pacific journal of oncology nursing vol. 4,2 (2017): 98-103. doi: https://doi.org/10.4103/2347-5625.204497
Boyle DA. Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):98-103. doi: 10.4103/2347-5625.204497. PMID: 28503639; PMCID: PMC5412161.
Copy Download .nbib Format: NLM
Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up.

Journal of oncology

Ferrer-Santacreu EM, Ortiz-Cruz EJ, Díaz-Almirón M, Pozo Kreilinger JJ.
PMID: 27034667
J Oncol. 2016;2016:8262079. doi: 10.1155/2016/8262079. Epub 2016 Feb 23.

As of today two types of cartilage tumors remain a challenge even for the orthopedic oncologist: enchondroma (E), a benign tumor, and chondrosarcoma (LGC), a malignant and low aggressiveness tumor. A prospective study of 133 patients with a cartilaginous...

Cite
Ferrer-Santacreu EM, Ortiz-Cruz EJ, Díaz-Almirón M, et al. Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up. J Oncol. 2016;2016:8262079doi: 10.1155/2016/8262079.
Ferrer-Santacreu, E. M., Ortiz-Cruz, E. J., Díaz-Almirón, M., & Pozo Kreilinger, J. J. (2016). Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up. Journal of oncology, 20168262079. https://doi.org/10.1155/2016/8262079
Ferrer-Santacreu, Eugenio M, et al. "Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up." Journal of oncology vol. 2016 (2016): 8262079. doi: https://doi.org/10.1155/2016/8262079
Ferrer-Santacreu EM, Ortiz-Cruz EJ, Díaz-Almirón M, Pozo Kreilinger JJ. Enchondroma versus Chondrosarcoma in Long Bones of Appendicular Skeleton: Clinical and Radiological Criteria-A Follow-Up. J Oncol. 2016;2016:8262079. doi: 10.1155/2016/8262079. Epub 2016 Feb 23. PMID: 27034667; PMCID: PMC4791495.
Copy Download .nbib Format: NLM
Long-term stability of ganciclovir in polypropylene containers at room temperature.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S.
PMID: 28975863
J Oncol Pharm Pract. 2017 Jan 01;1078155217732629. doi: 10.1177/1078155217732629. Epub 2017 Jan 01.

Purpose Ganciclovir is increasingly provided by hospital pharmacy production unit in a ready-to-use form, in order to improve the safety of healthcare workers and the efficiency of the organisation. The objective of this study was to develop a stability-indicating...

Cite
Guichard N, Bonnabry P, Rudaz S, et al. Long-term stability of ganciclovir in polypropylene containers at room temperature. J Oncol Pharm Pract. 2017;1078155217732629doi: 10.1177/1078155217732629.
Guichard, N., Bonnabry, P., Rudaz, S., & Fleury-Souverain, S. (2017). Long-term stability of ganciclovir in polypropylene containers at room temperature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 1078155217732629. https://doi.org/10.1177/1078155217732629
Guichard, Nicolas, et al. "Long-term stability of ganciclovir in polypropylene containers at room temperature." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. (2017): 1078155217732629. doi: https://doi.org/10.1177/1078155217732629
Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S. Long-term stability of ganciclovir in polypropylene containers at room temperature. J Oncol Pharm Pract. 2017 Jan 01;1078155217732629. doi: 10.1177/1078155217732629. Epub 2017 Jan 01. PMID: 28975863.
Copy Download .nbib Format: NLM
Effect of resveratrol on cancer progression through the REG Ⅲ expression pathway in head and neck cancer cells.

International journal of oncology

Mikami S, Ota I, Masui T, Itaya-Hironaka A, Shobatake R, Okamoto H, Takasawa S, Kitahara T.
PMID: 27633858
Int J Oncol. 2016 Oct;49(4):1553-1560. doi: 10.3892/ijo.2016.3664. Epub 2016 Aug 19.

Identification of reliable markers of chemo- and radiosensitivity and the key molecules that enhance the susceptibility of head and neck squamous cell carcinoma (HNSCC) to anticancer treatments is highly desirable. Previously, we have reported that regenerating gene (REG) Ⅲ...

Cite
Mikami S, Ota I, Masui T, et al. Effect of resveratrol on cancer progression through the REG Ⅲ expression pathway in head and neck cancer cells. Int J Oncol. 2016;49(4):1553-1560doi: 10.3892/ijo.2016.3664.
Mikami, S., Ota, I., Masui, T., Itaya-Hironaka, A., Shobatake, R., Okamoto, H., Takasawa, S., & Kitahara, T. (2016). Effect of resveratrol on cancer progression through the REG Ⅲ expression pathway in head and neck cancer cells. International journal of oncology, 49(4), 1553-1560. https://doi.org/10.3892/ijo.2016.3664
Mikami, Shinji, et al. "Effect of resveratrol on cancer progression through the REG Ⅲ expression pathway in head and neck cancer cells." International journal of oncology vol. 49,4 (2016): 1553-1560. doi: https://doi.org/10.3892/ijo.2016.3664
Mikami S, Ota I, Masui T, Itaya-Hironaka A, Shobatake R, Okamoto H, Takasawa S, Kitahara T. Effect of resveratrol on cancer progression through the REG Ⅲ expression pathway in head and neck cancer cells. Int J Oncol. 2016 Oct;49(4):1553-1560. doi: 10.3892/ijo.2016.3664. Epub 2016 Aug 19. PMID: 27633858.
Copy Download .nbib Format: NLM
[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies.

International journal of oncology

Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M.
PMID: 27634111
Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16.

Following the publication of this article, an interested reader drew to our attention an anomaly associated with the presen-tation of the Fig. 2D; specifically, there appeared to have been a duplication of the same β-actin control band for the...

Cite
Yamamoto H, Oshiro R, Ohtsuka M, et al. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2016;49(5):2186doi: 10.3892/ijo.2016.3694.
Yamamoto, H., Oshiro, R., Ohtsuka, M., Uemura, M., Haraguchi, N., Nishimura, J., Takemasa, I., Mizushima, T., Doki, Y., & Mori, M. (2016). [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. International journal of oncology, 49(5), 2186. https://doi.org/10.3892/ijo.2016.3694
Yamamoto, Hirofumi, et al. "[Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies." International journal of oncology vol. 49,5 (2016): 2186. doi: https://doi.org/10.3892/ijo.2016.3694
Yamamoto H, Oshiro R, Ohtsuka M, Uemura M, Haraguchi N, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M. [Corrigendum] Distinct expression of C4.4A in colorectal cancer detected by different antibodies. Int J Oncol. 2016 Nov;49(5):2186. doi: 10.3892/ijo.2016.3694. Epub 2016 Sep 16. PMID: 27634111; PMCID: PMC5063454.
Copy Download .nbib Format: NLM
[Corrigendum] Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2.

International journal of oncology

Ma L, Liu Y, Geng C, Qi X, Jiang J.
PMID: 27634304
Int J Oncol. 2016 Nov;49(5):2187. doi: 10.3892/ijo.2016.3695. Epub 2016 Sep 16.

Following the publication of this article, an interested reader drew to our attention an anomaly associated with Fig. 2, which presented the results of a wound‑healing assay performed to determine whether estradiol (E2) was able to exert an influence...

Cite
Ma L, Liu Y, Geng C, et al. [Corrigendum] Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2. Int J Oncol. 2016;49(5):2187doi: 10.3892/ijo.2016.3695.
Ma, L., Liu, Y., Geng, C., Qi, X., & Jiang, J. (2016). [Corrigendum] Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2. International journal of oncology, 49(5), 2187. https://doi.org/10.3892/ijo.2016.3695
Ma, Li, et al. "[Corrigendum] Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2." International journal of oncology vol. 49,5 (2016): 2187. doi: https://doi.org/10.3892/ijo.2016.3695
Ma L, Liu Y, Geng C, Qi X, Jiang J. [Corrigendum] Estrogen receptor β inhibits estradiol-induced proliferation and migration of MCF-7 cells through regulation of mitofusin 2. Int J Oncol. 2016 Nov;49(5):2187. doi: 10.3892/ijo.2016.3695. Epub 2016 Sep 16. PMID: 27634304; PMCID: PMC5066321.
Copy Download .nbib Format: NLM
Pulmonary Venous Obstruction in Cancer Patients.

Journal of oncology

Liaw CC, Chang H, Yang TS, Wen MS.
PMID: 26425121
J Oncol. 2015;2015:210916. doi: 10.1155/2015/210916. Epub 2015 Sep 06.

Background. We study the clinical significance and management of pulmonary venous obstruction in cancer patients. Methods. We conducted a prospective cohort study to characterize the syndrome that we term "pulmonary vein obstruction syndrome" (PVOS) between January 2005 and March...

Cite
Liaw CC, Chang H, Yang TS, et al. Pulmonary Venous Obstruction in Cancer Patients. J Oncol. 2015;2015:210916doi: 10.1155/2015/210916.
Liaw, C. C., Chang, H., Yang, T. S., & Wen, M. S. (2015). Pulmonary Venous Obstruction in Cancer Patients. Journal of oncology, 2015210916. https://doi.org/10.1155/2015/210916
Liaw, Chuang-Chi, et al. "Pulmonary Venous Obstruction in Cancer Patients." Journal of oncology vol. 2015 (2015): 210916. doi: https://doi.org/10.1155/2015/210916
Liaw CC, Chang H, Yang TS, Wen MS. Pulmonary Venous Obstruction in Cancer Patients. J Oncol. 2015;2015:210916. doi: 10.1155/2015/210916. Epub 2015 Sep 06. PMID: 26425121; PMCID: PMC4575742.
Copy Download .nbib Format: NLM
Epithelial to Mesenchymal Transition in a Clinical Perspective.

Journal of oncology

Pasquier J, Abu-Kaoud N, Al Thani H, Rafii A.
PMID: 26425122
J Oncol. 2015;2015:792182. doi: 10.1155/2015/792182. Epub 2015 Sep 06.

Tumor growth and metastatic dissemination rely on cellular plasticity. Among the different phenotypes acquired by cancer cells, epithelial to mesenchymal transition (EMT) has been extensively illustrated. Indeed, this transition allows an epithelial polarized cell to acquire a more mesenchymal...

Cite
Pasquier J, Abu-Kaoud N, Al Thani H, et al. Epithelial to Mesenchymal Transition in a Clinical Perspective. J Oncol. 2015;2015:792182doi: 10.1155/2015/792182.
Pasquier, J., Abu-Kaoud, N., Al Thani, H., & Rafii, A. (2015). Epithelial to Mesenchymal Transition in a Clinical Perspective. Journal of oncology, 2015792182. https://doi.org/10.1155/2015/792182
Pasquier, Jennifer, et al. "Epithelial to Mesenchymal Transition in a Clinical Perspective." Journal of oncology vol. 2015 (2015): 792182. doi: https://doi.org/10.1155/2015/792182
Pasquier J, Abu-Kaoud N, Al Thani H, Rafii A. Epithelial to Mesenchymal Transition in a Clinical Perspective. J Oncol. 2015;2015:792182. doi: 10.1155/2015/792182. Epub 2015 Sep 06. PMID: 26425122; PMCID: PMC4575734.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 6629 entries